Tyra Biosciences
TYRA
49 hedge funds and large institutions have $320M invested in Tyra Biosciences in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
25% more capital invested
Capital invested by funds: $256M → $320M (+$64.2M)
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
2% more funds holding
Funds holding: 48 → 49 (+1)
1.07% more ownership
Funds ownership: 85.6% → 86.67% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$5.96M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$532K |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$451K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$277K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$440K |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$434K |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$359K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$313K |
| 5 |
D.E. Shaw & Co
New York
|
-$194K |
TYRA Hedge Fund Activity: Q3 2022 in Review
49 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q3 2022, worth a combined $320M — up 25% from $256M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TYRA positions and 3 closed out — a net gain of 1 holder — while 17 added to existing stakes and 15 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $5.96M. The largest seller was Woodline Partners, cutting an estimated $440K.
- 49 institutional investors held Tyra Biosciences (TYRA) as of Q3 2022, up from 48 in Q2 2022.
- Funds reported $320M of Tyra Biosciences stock for Q3 2022, up 25% quarter-over-quarter.
- 4 funds opened new Tyra Biosciences positions in Q3 2022 and 3 closed out, a net change of +1 holder.
- The largest Tyra Biosciences buyer in Q3 2022 was Janus Henderson Group, an estimated $5.96M added.
- The largest Tyra Biosciences seller in Q3 2022 was Woodline Partners, an estimated $440K sold.
Based on aggregated 13F filings for Q3 2022.